FENNEC PHARMACEUTICALS INC (FRX.CA) Stock Cash Flow
Canada - Toronto Stock Exchange - TSX:FRX - CA31447P1009 - Common Stock
10.54 CAD
-0.16 (-1.5%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -6.94M | -436.00K | -16.05M | -23.71M | -17.35M | |||
| Change In Working Capital | -6.74M | 17.00M | -6.78M | 1.10M | -930.00K | |||
| Taxes Paid | 167.00K | 176.00K | 78.00K | 190.00K | N/A | |||
| Other non cash items | 5.69M | 10.42M | 5.68M | 4.55M | 4.06M | |||
| OPERATING CASH FLOW | -7.53M | 26.98M | -17.14M | -18.06M | -14.22M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | N/A | N/A | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -13.00M | -14.74M | 5.00M | 19.94M | 5.00M | |||
| Stock Issued/Repurchased | 2.79M | 1.30M | 1.72M | 930.00K | 30.00K | |||
| Other Financing Activity | -167.00K | -176.00K | -75.00K | -130.00K | -60.00K | |||
| FINANCING CASH FLOW | -10.39M | -13.62M | 6.64M | 20.73M | 4.98M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | -18.32M | 13.37M | -10.51M | 2.67M | -9.24M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.53M | 26.98M | -17.14M | -18.06M | -14.22M | |||
| FREE CASH FLOW | -7.53M | 26.98M | -17.14M | -18.06M | -14.22M | |||
All data in USD